For current share price click on graph below
Trading Information:
Shares admitted to trading on AIM on 15 January 2008. On admission to AIM, the Company delisted from PLUS Markets. Excepting AIM the Company has not applied or agreed to have any of its securities admitted or traded on any other exchanges or trading platforms.
ISIN: GB0032350695
SEDOL: 3235069
TIDM: ANCR
Supersector: Healthcare
Sector: Pharmaceuticals & Biotechnology
Subsector: Pharmaceuticals
Normal market size:
Allotted, issued and fully paid up shares Number Value
Ordinary shares of 20p each (listed on AIM) 20,510,204 £4,102,141
Percentage of securities not in public hands 14.3%
Restriction on the transfer of securities NONE
Securities held in Treasury Shares NONE
Significant shareholders (3% or more of the ordinary share capital) as at 04/01/2012
Brewin Dolphin 2,309,564 11.3%
Including the beneficial shareholding of
J S Lambert of 1,286,691 shares (6.3 per cent)
Investec Wealth Management Limited 1,965,227 9.6%
Including the shareholding of
S F Riddell of 1,017,727 shares (5.0 per cent)*
Octopus Investments 1,687,356 8.2%
Unicorn Asset Management 1,636,963 8.0%
Lord Downshire** 1,420,029 7.0%
Liontrust Asset Management 1,309,785 6.4%
Hargreave Hale 1,202,997 5.9%
Cazenove Capital Management*** 1,104,784 5.4%
Williams de Broe 840,347 4.1%
* S F Riddell's shareholding includes a non-beneficial interest in 315,000 ordinary shares.
**Lord Downshire's shareholding includes a total non-beneficial interest in 310,446 ordinary shares.
***Cazenove Capital Management's shareholding includes Lord Downshire's non-beneficial interest in 273,636 ordinary shares.
For independent investment research follow this link to Edison Investment Research.